Envisioned Future

1. To develop personalised medicine in infectious diseases (ID) for better health
   
2. To leverage Health IT and data analytics for better patient care
   
3. To perform health technology assessments of antimicrobial resistance (AMR)/ pandemic prevention and treatment options for lower healthcare costs
   
4. To push the boundaries of research against priority pathogens by evaluating cutting-edge technologies in the prevention and management of priority pathogens using translational research
   
5. To accelerate translational clinical research for emerging pathogens of pandemic threats through the Viral Research and Experimental Medicine Centre (ViREMiCS).
   

Key Strategies

Research Peak Leads

​	​
​Assoc Prof Andrea Kwa Lay Hoon Specialty: Anitmicrobial Resistance Deputy Director Pharmacy (R&I), Pharmacy-Inpatient Singapore General Hospital	​Assoc Prof Jenny Low Specialty: Infectious Diseases Senior Consultant Infectious Diseases Singapore General Hospital